Literature DB >> 2574627

The effects of terfenadine with and without alcohol on an aspect of car driving performance.

J Z Bhatti1, I Hindmarch.   

Abstract

Twelve healthy female volunteers received acute doses of terfenadine, 60 mg, 120 mg, 240 mg or placebo, followed by a 'social' dose of alcohol equivalent to 0.5 g absolute alcohol/kg body weight. Performance was assessed on laboratory analogues of car driving both before and after alcohol administration. Terfenadine (240 mg) was found to significantly impair performance alone and following alcohol. The results demonstrate the importance of establishing the behavioural effects of drugs over a range of doses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574627     DOI: 10.1111/j.1365-2222.1989.tb02754.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  10 in total

Review 1.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

3.  Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.

Authors:  Consuelo García-Gea; Maria Rosa Ballester; Juan Martínez; Rosa Maria Antonijoan; Esther Donado; Iñaki Izquierdo; Manuel-José Barbanoj
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

Review 4.  Comparative tolerability of second generation antihistamines.

Authors:  F Horak; U P Stübner
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

Review 5.  Effects of terfenadine on psychomotor performance. An overview.

Authors:  D W Aaronson
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

6.  Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers.

Authors:  A Patat; M C Perault; B Vandel; N Ulliac; I Zieleniuk; P Rosenzweig
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

7.  Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects.

Authors:  A Patat; D Stubbs; C Dunmore; N Ulliac; B Sexton; I Zieleniuk; A Irving; W Jones
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 8.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

9.  Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.

Authors:  K Yanai; J H Ryu; T Watanabe; R Iwata; T Ido; Y Sawai; K Ito; M Itoh
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing.

Authors:  J G Ramaekers; J F O'Hanlon
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.